InvestorsHub Logo
Followers 84
Posts 32232
Boards Moderated 85
Alias Born 03/22/2005

Re: None

Monday, 09/12/2016 12:01:13 PM

Monday, September 12, 2016 12:01:13 PM

Post# of 45320
The new slide deck for the R+R presentation is up on the RespireRx website -


http://respirerx.com/


Looks like the next clinical trial might be using CX-1739 for Central Sleep Apnea in patients on chronic opioid therapy (protocol for the proposed trial on slide 20).

Also possible plans for a CX-717 trial for patients with spinal cord injuries involving impaired respiration (slides 21-23, trial protocol slide 25).


The just released CX-1739 RD trial preliminary results leave many unanswered questions

(continued next post)








Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News